Biomolecular Life Holdings, Inc. BIOM
OTC PK
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 62.90K | 64.00K | 66.30K | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 62.90K | 64.00K | 66.30K | ||
| Operating Income | -62.90K | -64.00K | -66.30K | ||
| Income Before Tax | -883.80K | -337.10K | -303.50K | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -883.80K | -337.10K | -303.50K | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -883.80K | -337.10K | -303.50K | ||
| EBIT | -62.90K | -64.00K | -66.30K | ||
| EBITDA | -- | -- | -- | ||
| EPS Basic | -0.07 | -0.32 | -0.29 | ||
| Normalized Basic EPS | -0.04 | -0.20 | -0.18 | ||
| EPS Diluted | -0.07 | -0.32 | -0.29 | ||
| Normalized Diluted EPS | -0.04 | -0.20 | -0.18 | ||
| Average Basic Shares Outstanding | 12.60M | 1.06M | 1.05M | ||
| Average Diluted Shares Outstanding | 12.60M | 1.06M | 1.05M | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||